GoIP to Launch CancerTXT

100,000 Members Expected by End 2009


NEW YORK, NY--(MARKET WIRE)--Jul 11, 2008 -- GoIP Global, Inc. (Other OTC:GOIG.PK - News) announced the beta launch of CancerTXT, a Text messaging service to provide Cancer patients and family members with basic real time information and references. Consumers can join CancerTXT for a $4.95 monthly membership fee and be able to send unlimited text questions over their cell phones and receive an immediate response from a trained social worker. This immediate support vehicle will be available on ALL CELL PHONE DEVICES subject to the Carrier's approval. Based on initial market studies it is expected that 100,000 members will be registered nationwide by the end of 2009.
Moshe Gluzman, GoIP's Health Director, commented, "This new mobile messaging service will change the way patients and family members can access essential information. They simply Text a question to CancerTXT and a response or support information will be immediately received. We are excited to use this new media channel effectively and provide valuable timely information to many." For more information about this specific program please contact Moshe Gluzman at mgluzman@goipglobal.com.

About GoIP Global, Inc.

GoIP Global is a technology provider and developer of innovative Value added Services (VAS) solutions for the mobile marketplace. Its flagship product, the GoIP Global Server, is a middleware platform that links businesses with their customers through the mobile network infrastructure. GoIP Global solutions address the various business needs of network operators, service providers, retailers, vendors and media, looking to deploy new mobile services to create alternative sources of revenue and to interact with their customers with personalized solutions to suit their needs and requirements. For addition information, visit, www.goipglobal.com.

Safe Harbor Statements under the Private Securities Litigation Reform Act of 1995: Those statements contained herein which are not historical are forward-looking statements, and as such, are subject to risks and uncertainties that could cause actual operating results to materially differ from those contained in the forward-looking statements. Such statements include, but are not limited to, certain delays that are beyond the Company's control, with respect to market acceptance of new technologies, or product delays in the testing and evaluation of products, and other risks, as detailed in the Company's periodic filings.